Prehospital and interhospital delay in the treatment of patients with acute myocardial infarction with ST segment elevation and strategies to improve it from the perspective of the process owners: The importance of time

authors:

avatar Somayeh Rezaie , avatar Nadia Gharanjici , avatar Hossain Ebrahimi , *

Koomesh: Vol.21, issue 3; 460-469
published online: September 03, 2019
article type: Research Article
received: April 01, 2018
accepted: March 03, 2019

how to cite: Rezaie S, Gharanjici N, Ebrahimi H. Prehospital and interhospital delay in the treatment of patients with acute myocardial infarction with ST segment elevation and strategies to improve it from the perspective of the process owners: The importance of time. koomesh. 2019;21(3):e153092. 

Abstract

Introduction: Fibrinolytic drugs are one of the important strategies for the treatment of patients with acute myocardial infarction with ST segment elevation, especially in small centers. This study was conducted with the aim of evaluating the distance with the global standard for fibrinolytic treatment and the viewpoints of experts in this regard. Materials and Methods: This cross-sectional study was performed on 384 patients with acute myocardial infarction in Imam Hossein Hospital in Shahroud, Iran during a 5-year period. Data were collected using a demographic and medical profile and a 13-item checklist on how and when access to treatment and services and interviewed by the treatment team was sought. Results: Out of 384 patients, %76.3 was male and the mean age was 60.4 years. Prehospital delay, electrocardiography time, and first visit time respectively were 270, 6.59 and 8.45 minute, generally, the door-to- needle time was more than three times the global standard. Prehospital delay with gender, history of diabetes and high blood pressure, education level, and history of percutaneous coronary intervention(PCI) were significant (p

References

  • 1.

    Asaria P, Elliott P, Douglass M, Obermeyer Z, Soljak M, Majeed A, et al. Acute myocardial infarction hospital admissions and deaths in England: a national follow-back and follow-forward record-linkage study. The Lancet Public Health 2017; 2: e191-e20.

  • 2.

    Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald U. Braunwalds heart disease a textbook of cardiovascular medicine. Elsevier Saunders 2015.

  • 3.

    Ahmadi A, Soori H, Mehrabi Y, Etemad K, Samavat T, Khaledifar A. Incidence of acute myocardial infarction in Islamic Republic of Iran: A study using national registry data in 2012. East Mediterr Health J 2015; 21: 5-12.

  • 4.

    Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Dis Mon 2013; 59: 83-96.

  • 5.

    Hoseinian A, Pourfarzi F, Sepahvand N, Habibzadeh SH, Babapour B, Doostkami H, et al. The study of interval between onset of the clinical symptoms and streptokinase receiving in patients with acute myocardial infarction. J Ardabil Univ Med Sci 2012; 12: 16-24. (Persian).

  • 6.

    Karimyar Jahromy M. Acure coronary syndrom. Boshra Tehran 1392; p: 120-125. (Persian).

  • 7.

    Bolvardi E, Feizdisfani H, Kamandi M. The effect of ESI triage, in improving the time of fibrinolytic therapy in patients with acute ST-elevation MI. Med J Mashhad 2014; 57: 495-504. (Persian).

  • 8.

    Pride YB, Canto GJ, Frederick PD, Gipson M. Outcomes among patients with non-ST-segment elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery. Circ Cardiovasc Qual Outcomes is available at http://circoutcomes.ahajournals.org.

  • 9.

    Ting HH, Bradley EH, Wang Y, Lichtman JH, Nallamothu BK, Sullivan MD, et al. Factors aesentation for patients with ST-Elevation myocardial infarction. Arch Int Med 2008; 168: 959-968.

  • 10.

    Huber K, De Caterina R, Kristensen SD, Verheugt FW, Montalescot G, Maestro LB, et al. Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur Heart J 2005; 26: 2063-2074.

  • 11.

    Huynh T, O'Loughlin J, Joseph L, Schampaert E, Rinfret S, Afilalo M, et al. Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. CMAJ 2006; 175: 1527-1532.

  • 12.

    Fukuoka Y, Dracup K, Ohno M, Kobayashi F, Hirayama H. Predictors of in-hospital delay to reperfusion in patients with acute myocardial infarction in Japan. J Emerg Med 2006; 31: 241-245.

  • 13.

    Samadikhah J, Alizade M, Rezaeifar P, Ahadpour A. Delays in administration of streptokinase in patients with acute myocardial infarction hospitalized in Shahid Madani hospital of Tabriz university of medical science. Med J Tabriz Univ Med Sci 2007; 29: 71-5. (Persian).

  • 14.

    Rajabi-Moghadam H, Raygan F, Noureddini M, Mousavi GA, Taghadosi M, Zahedi M. Evaluating in-hospital delay for fibrinolytic therapy of myocardial infarction patients with acute ST-elevation in Kashan Shahid-Beheshti hospital during 20072010. Feyz 2012; 16: 468-475. (Persian).

  • 15.

    McNamara RL, Herrin J, Wang Y, Curtis JP, Bradley EH, Magid DJ, et al. Impact of delay in door-to-needle time on mortality in patients with ST-Segment elevation myocardial infarction. Am J Cardiol 2007; 100: 1227-1232.

  • 16.

    Ho AF, Pek PP, Fook-Chong S, Wong TH, Ng YY, Wong AS, Ong ME. Prehospital system delay in patients with ST-segment elevation myocardial infarction in Singapore. World J Emerg Med 2015; 6: 277-282.

  • 17.

    George L, Ramamoorthy L, Satheesh S, Saya RP, Subrahmanyam DK. Prehospital delay and time to reperfusion therapy in ST elevation myocardial infarction. J Emerg Trauma Shock 2017; 10: 64-69.

  • 18.

    Loch A, Lwin T, Zakaria IM, Abidin IZ, Wan Ahmad WA, Hautmann O. Failure to improve door-to-needle time by switching to emergency physician-initiated thrombolysis for ST elevation myocardial infarction. Postgrad Med J 2013; 89: 335-339.

  • 19.

    Zeraati F, Homayounfar SH, Esna-Ashar FI, Khalili M. Fibrinolytic therapy in CCU instead of emergency ward: how it affects door to needle time? Int J Prev Med 2014; 5: 308-312.

  • 20.

    Jordan M, Caesar J. Improving door-to-needle times for patients presenting with ST-elevation myocardial infarction at a rural district general hospital. BMJ Qual Improv Rep 2016; 5.

  • 21.

    Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald U. Braunwalds heart disease a textbook of cardiovascular medicine. Elsevier Saunders 2018.

  • 22.

    Ebrahimi K, Khadem Vatan K, Salarilak S, Gharaaghaji R. Epidemiological features of risk factors occurrence and outcomes of myocardial infraction in patients admitted to hospitals in west Azerbaijan province during the years 2011 and 2012. Urmia Med J 2015; 26: 724-734. (Persian).

  • 23.

    Sarafraz yazdi M, Sadeghi Ordubadi M, Roshandel E. The relationship between CRP and one-month mortality rate in patients with acute stroke in Arya Hospital during one year. Med Sci J 2015; 5: 12-24 (Persian).

  • 24.

    Alishahi tabriz A, Sohrabi MR, Kiapour N, Yazdani SH. Factors associated with delay in thrombolytic therapy in patients with ST-elevation myocardial infarction. J Tehran Heart Cent 2012; 7: 65-71.

  • 25.

    Momeni M, Salari A, Shafighnia S, Ghanbari A, Mirbolouk F. Factors influencing pre hospital delay among patients with acute myocardial infarction in Iran. Chin Med J 2012; 125: 3404-3409.

  • 26.

    Park YH, Kang GH, Song BG, Chun WJ, Lee JH, Hwang SY, et al. Factors related to prehospital time delay in acute ST-Segment elevation myocardial infarction. J Korean Med Sci 2012; 27: 864-869.

  • 27.

    Song L, Yan HB, Yang JG, Sun YH, DY H. Impact of patients' symptom interpretation on care-seeking behaviors of patients with acute myocardial infarction. Chin Med J 2010; 123: 1840-1845.

  • 28.

    tacey RB, Zgibor J, Hall ME, Schocken D, Leaverton PE. Diabetes is associated with unrecognized myocardial infarctions in African-Americans: the Jackson heart study. Circulation 2017; 136: A19133.

  • 29.

    Arslanian-Engoren C, Patel A, Fang J, Armstrong D, Kline-Rogers E, Duvernoy C.S, Eagle KA. Symptoms of men and women presenting with acute coronary syndromes. Ame J Cardiol 2006; 98: 1177-1118.

  • 30.

    Kosuge M, Kimura K, Ishikawa T, Ebina T, Hibi K, Tsukahara K, et al. Differences between men andwomen in term of clinical features of ST-segmentelevation acute myocardial infarction. Cric J 2006; 70: 222-226.

  • 31.

    Farshidi H, Rahimi S, Abdi A, Salehi S, Madani A. Factors associated with pre-hospital delay in patients with acute myocardial infarction. Iran Red Crescent Med J 2013; 15: 312-316.

  • 32.

    Hoseinian A, Pourfarzi F, Sepahvand N, Habibzadeh SH, Babapour B, Doostkami H, et al. The study of interval between onset of the clinical symptoms and streptokinase receiving in patients with acute myocardial infarction. J Ardabil Univ Med Sci 2012; 12: 16-24. (Persian).

  • 33.

    Zalenski RJ, Selker HP, Cannon CP, Farin HM, Gibler WB, Goldberg RJ, et al. National heart attack alert program position paper: chest pain centers and programs for the evaluation of acute cardiac ischemia. Ann Emerg Med 2000; 35: 462-471.

  • 34.

    Kalantari Meibodi M. Door to electrocardiography (ECG) and needle times in patients with myocardial infarction. Emergency 2014; 2: 150.

  • 35.

    Omraninava A, Hashemian AM, Masoumi B. Effective factors in door-to-needle time for streptokinase administration in patients with acute myocardial infarction admitted to the emergency department. Trauma Monthly 2016; 21: e19676.

  • 36.

    Abba AA, Wani BA, Rahmatullah RA, Khalil MZ, Kumo AM. Door to needle time in administering thrombolytic therapy for acute myocardial infarction. Saudi Med J 2003; 24: 361-364.

  • 37.

    Schull MJ, Vermeulen M, Slaughter G, Morrison L, Daly P. Emergency department crowding and thrombolysis delays in acute myocardial infarction. Ann Emerg Med 2004; 44: 577-585.

  • 38.

    Huynh T, O'Loughlin J, Joseph L, Schampaert E, Rinfret S, Afilalo M, et al. Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMIQUEBEC Study. CMAJ 2006; 175: 1527-1523.

  • 39.

    Huber K, De Caterina R, Kristensen SD, Verheugt FW, Montalescot G, Maestro LB, et al. Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with STelevation myocardial infarction. Eur Heart J 2005; 26: 2063-2074.

  • 40.

    Ting HH, Bradley EH, Wang Y, Nallamothu BK, Curtis JP, Gersh BJ, et al. Relationship between time form symptom onset to hospital presentation and treatment with and timeliness of reperfusion therapy for patients with STElevation myocardial infarction. Circulation 2007; 116: 11-79.

  • 41.

    Fang K, Churilov L, Weir L, Dong Q, Davis S, Yan B. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome? J Stroke Cerebrovasc Dis 2014; 23: 427-432.

  • 42.

    Atzema CL Austin PC, Tu JV, Schull MJ. Emergency department triage of acute myocardial infarction patients and the effect on outcomes. Ann Emerg Med 2009; 53: 736-745.

  • 43.

    Herlitz J, WireklintSundstrm B, Bng A, Berglund A, Svensson L, Blomstrand C. Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities. Scand J Trauma Resusc Emerg Med 2010; 18: 48.

  • 44.

    Zeraati F, Homayounfar S, Esna-Ashari F, Khalili. Fibrinolytic therapy in CCU instead of emergency ward: how it affects door to needle time? Int J Prev Med 2014; 5: 308-312.

  • 45.

    Mathews R, Peterson ED, Li S, Roe MT, Glickman SW, Wiviott SD, Saucedo JF, et al. Use of emergency medical service transport among patients with STsegment-elevation myocardial infarction: findings from the national cardiovascular data registry acute coronary treatment intervention outcomes network registry-get with the guidelines. Circulation 2011; 124: 154-163.##.